10-Q: GridAI Technologies Corp. Q1 2026 Financial Update

GridAI Technologies Corp. reports a net loss of $3.44 million for Q1 2026, with revenue generated from its new AI energy segment.

Summary

• GridAI Technologies Corp. reported a net loss of $3,438,702 for the first quarter ended March 31, 2026, compared to a net loss of $1,259,620 for the same period in 2025.
• Revenue for the quarter was $38,208, entirely from the new AI Segment, a significant increase from zero revenue in the prior year's quarter.
• Operating expenses increased substantially to $3,000,758 from $821,386 in Q1 2025, driven by higher R&D and G&A expenses.
• The company had cash and cash equivalents of $385,542 as of March 31, 2026, and an accumulated deficit of $212.1 million.
• Substantial doubt exists about the company's ability to continue as a going concern without additional financing.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this filing as having a negative sentiment due to the increased net loss, substantial rise in operating expenses, and the persistent going concern warning, despite some positive developments in revenue generation from the new AI segment and recent capital raises.

Positives

• Generated $38,208 in revenue from the new AI Segment, marking the first revenue reported from this business line.
• Regained compliance with Nasdaq minimum bid price requirement in September 2025 and subsequently with the annual meeting requirement.
• Successfully settled a significant legal dispute with Ellenoff Grossman & Schole LLP for $360,000, with an initial payment made.
• Secured approximately $2.54 million in aggregate gross proceeds from private placement financing in May 2026, with an additional $5.25 million from a subsequent financing.
• Recognized $0.4 million in government grant income in Q1 2026 related to UK R&D tax credits.

Negatives

• Reported a net loss of $3,438,702 for Q1 2026, an increase from $1,259,620 in Q1 2025.
• Operating expenses surged by 265% to $3,000,758 in Q1 2026 compared to $821,386 in Q1 2025.
• Cash and cash equivalents decreased to $385,542 from $899,784 at the end of 2025.
• The company has an accumulated deficit of $212.1 million.
• The company received a notice of default on its revolving loan agreement in April 2026, though it was subsequently settled in May 2026.

Risks

• Substantial doubt exists about the company's ability to continue as a going concern due to recurring losses and negative cash flows.
• The company is dependent on obtaining additional working capital funding from equity and/or debt securities, which may not be available on acceptable terms.
• Failure to raise sufficient capital could force the company to delay, limit, or terminate operations, liquidate assets, or seek bankruptcy protection.
• The company faces risks related to maintaining compliance with Nasdaq listing requirements.
• The company's operations are subject to risks associated with geopolitical events, including the war in Ukraine and the Middle East, impacting operations and access to capital.

Future Outlook

The company expects to continue incurring net losses and negative cash flows for the foreseeable future. Future capital needs will depend on operating requirements of the AI and GI segments, corporate overhead, debt service, public company costs, and potential advancement of the Adrulipase program. The company remains dependent on external capital resources and future equity or debt financings may be dilutive.

Management Comments

• "Our future capital needs will depend on a number of factors, including the operating requirements of the GridAI and AMPX business, our corporate overhead, debt service obligations, public company costs and the extent to which we seek to preserve, resume or advance development activities relating to Adrulipase."
• "If we are unable to obtain additional financing when needed, on acceptable terms or at all, we may be required to delay, reduce or terminate operating activities, defer strategic initiatives, reduce headcount, dispose of assets, restructure obligations or pursue other alternatives that may materially adversely affect our business, financial condition and results of operations."
• "Although the Company has regained compliance with the foregoing Nasdaq listing requirements, there can be no assurance that the Company will continue to maintain compliance with all applicable Nasdaq continued listing standards in the future."

Industry Context

StockSavvy.ai notes that GridAI Technologies Corp. is navigating a complex transition, integrating a new AI-driven energy technology business while managing the legacy biopharmaceutical operations. The significant increase in operating expenses and continued net loss highlight the challenges of this dual-focus strategy and the ongoing need for external capital.

Legal Proceedings

• Settlement reached with Ellenoff Grossman & Schole LLP for $360,000 to resolve litigation over unpaid legal fees.

Related Party Transactions

• The company assumed deferred consideration liabilities of $7.0 million in connection with the Grid AI acquisition, with $6.25 million outstanding as of March 31, 2026.
• Amounts payable to related parties, including North York and Strategic EP LLC, for services provided.
• Consulting and service arrangements with certain members of management, including the CEO and CFO, through affiliated entities.
• Amended and Restated Consulting Agreement with Access Alternative Group S.A. (affiliated with the CEO) for services including CEO duties, with monthly base compensation and quarterly fees.

Stakeholder Impact

• Shareholders face continued dilution risk from potential future equity financings.
• The going concern warning indicates a significant risk to the company's ability to continue operations, impacting all stakeholders.
• Employees may face uncertainty regarding job security and company stability due to the going concern status.
• Creditors and lenders face potential risks if the company cannot meet its debt obligations, as evidenced by the prior default on the revolving loan.

Next Steps

• Continue to evaluate strategic alternatives for the legacy GI therapeutic assets.
• Continue development activities related to Adrulipase, subject to available capital and strategic priorities.
• Focus on integrating Grid AI's operations and commercializing its AI-driven energy optimization platform.
• Seek additional financing to fund operations and meet obligations.
• Continue to monitor and ensure compliance with Nasdaq listing requirements.

Key Dates

Recommendation

The company is in a critical transition phase with a new AI energy segment generating initial revenue, but also facing significant losses and a going concern warning. Recent capital raises provide some short-term relief, but the path to profitability remains uncertain. The dual-focus strategy presents execution risks. A 'hold' recommendation reflects the speculative nature of the turnaround and the need for further operational and financial progress before considering a more definitive stance.

Keywords

GridAI Technologies, SEC Filing, 10-Q, Quarterly Report, AI Energy, Biopharmaceutical, Financial Results, Net Loss, Going Concern, Capital Raise